Ctt Pharmaceutical Holdings Stock Performance
| CTTH Stock | USD 0.08 0.0005 0.63% |
CTT Pharmaceutical holds a performance score of 6 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 3.46, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, CTT Pharmaceutical will likely underperform. Use CTT Pharmaceutical value at risk, as well as the relationship between the skewness and day median price , to analyze future returns on CTT Pharmaceutical.
Risk-Adjusted Performance
Mild
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in CTT Pharmaceutical Holdings are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite fairly unfluctuating basic indicators, CTT Pharmaceutical demonstrated solid returns over the last few months and may actually be approaching a breakup point. ...more
CTT |
CTT Pharmaceutical Relative Risk vs. Return Landscape
If you would invest 6.98 in CTT Pharmaceutical Holdings on October 29, 2025 and sell it today you would earn a total of 1.02 from holding CTT Pharmaceutical Holdings or generate 14.61% return on investment over 90 days. CTT Pharmaceutical Holdings is currently generating 0.998% in daily expected returns and assumes 13.1047% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than CTT, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
CTT Pharmaceutical Target Price Odds to finish over Current Price
The tendency of CTT Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.08 | 90 days | 0.08 | roughly 2.55 |
Based on a normal probability distribution, the odds of CTT Pharmaceutical to move above the current price in 90 days from now is roughly 2.55 (This CTT Pharmaceutical Holdings probability density function shows the probability of CTT Pink Sheet to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days the pink sheet has the beta coefficient of 3.46 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, CTT Pharmaceutical will likely underperform. Additionally CTT Pharmaceutical Holdings has an alpha of 0.6963, implying that it can generate a 0.7 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). CTT Pharmaceutical Price Density |
| Price |
Predictive Modules for CTT Pharmaceutical
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as CTT Pharmaceutical. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of CTT Pharmaceutical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
CTT Pharmaceutical Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. CTT Pharmaceutical is not an exception. The market had few large corrections towards the CTT Pharmaceutical's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold CTT Pharmaceutical Holdings, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of CTT Pharmaceutical within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.70 | |
β | Beta against Dow Jones | 3.46 | |
σ | Overall volatility | 0.01 | |
Ir | Information ratio | 0.07 |
CTT Pharmaceutical Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of CTT Pharmaceutical for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for CTT Pharmaceutical can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| CTT Pharmaceutical is way too risky over 90 days horizon | |
| CTT Pharmaceutical has some characteristics of a very speculative penny stock | |
| CTT Pharmaceutical appears to be risky and price may revert if volatility continues | |
| CTT Pharmaceutical has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 40 K. Net Loss for the year was (1.38 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| CTT Pharmaceutical Holdings currently holds about 32.12 K in cash with (145.16 K) of positive cash flow from operations. |
CTT Pharmaceutical Fundamentals Growth
CTT Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of CTT Pharmaceutical, and CTT Pharmaceutical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on CTT Pink Sheet performance.
| Return On Equity | -4.49 | |||
| Return On Asset | -1.54 | |||
| Current Valuation | 18.87 M | |||
| Shares Outstanding | 21.32 M | |||
| Price To Earning | (3.00) X | |||
| Price To Book | 10.64 X | |||
| Revenue | 40 K | |||
| Cash And Equivalents | 32.12 K | |||
| Total Debt | 87.62 K | |||
| Debt To Equity | 0.12 % | |||
| Book Value Per Share | 0.04 X | |||
| Cash Flow From Operations | (145.16 K) | |||
| Earnings Per Share | (0.08) X | |||
| Total Asset | 186.54 K | |||
About CTT Pharmaceutical Performance
By evaluating CTT Pharmaceutical's fundamental ratios, stakeholders can gain valuable insights into CTT Pharmaceutical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if CTT Pharmaceutical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if CTT Pharmaceutical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
CTT Pharmaceutical Holdings, Inc. engages in the development of oral drug delivery systems for pain management and treatment. The company was formerly known as Mindesta Inc. and changed its name to CTT Pharmaceutical Holdings, Inc. in July 2015. Ctt Pharmaceutical is traded on OTC Exchange in the United States.Things to note about CTT Pharmaceutical performance evaluation
Checking the ongoing alerts about CTT Pharmaceutical for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for CTT Pharmaceutical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| CTT Pharmaceutical is way too risky over 90 days horizon | |
| CTT Pharmaceutical has some characteristics of a very speculative penny stock | |
| CTT Pharmaceutical appears to be risky and price may revert if volatility continues | |
| CTT Pharmaceutical has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 40 K. Net Loss for the year was (1.38 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| CTT Pharmaceutical Holdings currently holds about 32.12 K in cash with (145.16 K) of positive cash flow from operations. |
- Analyzing CTT Pharmaceutical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether CTT Pharmaceutical's stock is overvalued or undervalued compared to its peers.
- Examining CTT Pharmaceutical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating CTT Pharmaceutical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of CTT Pharmaceutical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of CTT Pharmaceutical's pink sheet. These opinions can provide insight into CTT Pharmaceutical's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for CTT Pink Sheet analysis
When running CTT Pharmaceutical's price analysis, check to measure CTT Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CTT Pharmaceutical is operating at the current time. Most of CTT Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of CTT Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CTT Pharmaceutical's price. Additionally, you may evaluate how the addition of CTT Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Transaction History View history of all your transactions and understand their impact on performance |